copyright 1 MG-SEMAGLUTIDE for Dummies
The demo obtained the two its Major endpoints, with semaglutide 2.4 mg demonstrating statistically substantial and superior advancements in liver fibrosis without any worsening of steatohepatitis, as well as resolution of steatohepatitis without worsening of liver fibrosis in people with MASH compared to placebo.1Talk to an correctly certified heal